Blue Gene's Protein Origami

By BIO-IT World

By Salvatore Salamone

August 13, 2002 | To get a sense of the computational power required to perform protein-folding calculations, one needs to look in more detail at what exactly is being simulated. A typical protein can have 30,000 atoms, surrounded by perhaps 500,000 water molecules.

With Blue Gene, IBM takes a molecular dynamics approach to studying protein folding. Each simulation starts with a model of a protein molecule within a solvent. In the real world, such a protein molecule would start to fold (or change shape) based on chemical attraction between the discrete atoms in the protein and the solvent molecules. To simulate protein folding, the effects of these chemical interactions are calculated for every atom in the protein and solvent.

The simulation program must take into account the forces on each atom and calculate each atom's position after these forces are applied over a time step (a set period of time). This process is done for every atom in the protein under investigation.

After a time step is completed, new forces are calculated and these forces are then applied to each atom again. The entire process is repeated multiple times. The end result is a calculation of the trajectory of all the atoms, so researchers can see where each atom is located as a function of time.

One of the key factors in a simulation of this type is the length of a time step. The bottom line is that smaller time steps yield a more accurate simulation. That's because each atom is influenced by all of the atoms around it; every time neighboring atoms move, the forces on a specific atom change. But a smaller time step means many more calculations must be done to simulate how a protein will ultimately behave over time.

So scientists must find some compromise. They must select a time step that is short enough to accurately account for the dynamics of the atoms in the protein, balanced against the number of computations that a shorter time step would entail.

To illustrate the relationship between the simulation time step and the computational capacity needed, IBM researchers picked a time step on the order of 10e-15 seconds. A time step this size can accurately describe the fastest vibrations of the protein and solvent system, according to IBM.

The folding time for a protein is about 10e-4 seconds. So the simulation program must perform the small time steps 10e+11 times on every atom to simulate that set duration. That's 100 billion steps.

In other words, the computational load is huge. In an IBM research paper Blue Gene: A vision for protein science using a petaflop supercomputer, (IBM Systems Journal, Vol. 40, No. 2, 2001), the authors noted that to do a straight molecular dynamics simulation of a protein folding over 10e-4 seconds would require about three years of computational time with a petaflop computer.

Thus, one of the challenges of the Blue Gene effort is to not just to produce faster hardware, but to also develop more efficient protein folding algorithms that decrease the computational tasks while still accurately simulating the real science that is happening. To that end, IBM has been conducting global workshops that bring scientists together to share the best practices for protein folding simulation.

—Salvatore Salamone 

Back to Think Blue... Again 


White Papers & Special Reports

thomson reuters image
Biomarkers: An Indispensible Addition to the Drug Development Toolkit
Examining the Potential of Biomarkers
Sponsored by Thomson Reuters

Biomarkers are becoming an essential part of clinical development. In this white paper, Thomson Reuters provides insight from experts in industry and academia, and explores the role of biomarkers as evaluative tools in improving clinical research and the challenges this presents.

Discover the potential of biomarkers to:

  • Improve decision making
  • Accelerate drug development
  • Reduce development costs


BlueArc_Scientific Data
Scientific Data Lifecycle Management: Preparing for Storage in an Uncertain Future
Sponsored by BlueArc

Managing vast and overwhelming streams of gene sequencing data today requires ultra-high performance systems and processes. With continued rapid advancement and improvements in gene sequencing, expect tomorrow’s instruments to output quantities of genomic information that will dwarf current levels. Help your organization maintain data control and prepare for the future of sequencing through this informative paper that discusses:

  • The information technology challenges of gene sequencing
  • “Intelligent” methods for data management and customization
  • System survival tips... Deciding what data to keep or delete
  • New tools to keep scientists ahead of impending data torrents


SAS Managed image
Managed Innovation, Assured Compliance
Developing, executing and managing the transformation, analysis and submission of clinical research data with SAS® Drug Development
Sponsored by SAS
Get better products to market faster. Download this white paper to discover the top ten challenges facing life science executives and how to overcome them. See how SAS Drug Development transforms clinical data into true innovation.


Life Science Webcasts & Podcasts

Presented by Trade Commission of Spain

Spain Biotech: An Engine for Economic Change 

TCS podcastDiscover how Spain is focusing on biotechnology to be an engine for economic change through gradual internationalization, development and technology transfer.

Regional governments are actively investing in public and private biology research and promoting the creation of knowledge-based companies. Spain’s human capital combined with aggressive investment in biotech research and infrastructure has led to the creation of bio-clusters.

Today, there are nearly 700 Spanish companies engaged in biotechnology, with almost 50 percent growth in funding devoted to research. In fact, spending on internal R & D in biotechnology has grown 46 percent and is close to 300 million Euros.

Access the podcast 

 



More Podcasts

Job Openings

saic_logo

MANAGER, SCIENTIFIC COMPUTING & PROGRAMMING
(Bioinformatics Manager)
SAIC-Frederick, Inc has an exciting opportunity for a Manager, Scientific Computing & Programming - Core Genoytyping Facility in Gaithersburg, Maryland.  In this role, you will lead the Bioinformatics & Analysis Group.
Master’s or equivalent required.  PhD preferred. Six years experience in development of scientific programs in high-performance computing environment including five years supporting scientific research in computational chemistry, biology, or genetics, & two years supervisory experience.  View complete job posting & apply: www.saic-frederick.com. Position #146945.

For reprints and/or copyright permission, please contact The YGS Group, 1808 Colonial Village Lane, Lancaster, PA;

(717) 399-1900 ext. 125, or via email to Ashley.Zander@theYGSgroup.com.